Stay updated on Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedA funding line for 2023 NIH grant/contract was added to the study page, and the revision history shows the page updated to version v3.6.6, replacing v3.6.5.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedPlain Language Summary text was removed from the Study Details page, eliminating the layperson-friendly overview of the trial's purpose and design. The remainder of the study details remains available.SummaryDifference0.0%

- Check24 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a newer version of the study page content. This likely reflects small updates or fixes applied by the publisher.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, indicating a small update to the page’s version. It does not change any study content or results.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision marker updated from v3.6.2 to v3.6.3, signaling a new page release. No study details or primary information appear to be altered.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This update appears to be a backend/content-management change rather than a substantive modification to the study details or eligibility criteria.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.